/

IDEXX Laboratories, Inc.

IDXX US

IDXX USIDEXX Laboratories, Inc.

United States Composite

494.26

USD

+0.46

(+0.09%)

10.06EPS Dil.

48.58P/E

41.04BMarket Cap

Next Earnings

April 30

Held by Insiders

1.11%

Held by Institutions

92.73%

Short % of Float

2.04%

YTD Yield

-0.76%

3Y Yield

-14.22%

5Y Yield

110.64%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

359

420

345

LT Borrowings

697

619

623

LT Finance Leases

101

100

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

41,715

36,323

46,087

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

1,179

1,384

1,495

Cash, Cash Equivalents & STI

133

332

454

Accounts Receivable, Net

462

453

457

Inventories

395

394

380

Total Current Liabilities

884

970

952

Payables & Accruals

362

355

395

ST Debt

359

420

345

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

10.33%

10.69%

8.73%

Net Income, GAAP

17.28%

18.62%

24.45%

Free Cash Flow

24.98%

33.37%

101.30%

Total Cash Common Dividend

- -

Total Equity

-182.47%

-336.21%

143.84%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

778

826

810

801

3,215

2022

837

861

842

829

3,367

2023

900

944

916

902

3,661

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

2.39

2.37

2.06

1.92

8.74

2022

2.30

1.57

2.17

2.08

8.12

2023

2.58

2.70

2.55

2.34

10.17

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Company Description

CEO: Mr. Jonathan J. Mazelsky
Full Time Employees: 11,000
Sector: Healthcare
Industry: Diagnostics & Research
Address: One IDEXX Drive Westbrook ME United States 04092
IPO Date: Jun 21, 1991
CIK: 0000874716
Website: www.idexx.com
Business: IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Company News

Zacks
22 days ago
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Yahoo
23 days ago
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
Zacks
23 days ago
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
Yahoo
a month ago
IDEXX Laboratories (IDXX) Gained 27% on Improved Operating Margins
Zacks
a month ago
Top Research Reports for Lam Research, PayPal & Trane
Yahoo
a month ago
Strong Fiscal Q3 Earnings Pushed IDEXX Laboratories (IDXX) in Q4
Yahoo
a month ago
IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 19% CAGR delivered to shareholders
Yahoo
a month ago
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Yahoo
2 months ago
Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc (IDXX)
Yahoo
2 months ago
Idexx (IDXX) Down 1.5% Since Last Earnings Report: Can It Rebound?
Zacks
2 months ago
Idexx (IDXX) Down 1.5% Since Last Earnings Report: Can It Rebound?

Company Description

CEO: Mr. Jonathan J. Mazelsky
Full Time Employees: 11,000
Sector: Healthcare
Industry: Diagnostics & Research
Address: One IDEXX Drive Westbrook ME United States 04092
IPO Date: Jun 21, 1991
CIK: 0000874716
Website: www.idexx.com
Business: IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Company News

Zacks
22 days ago
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Yahoo
23 days ago
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
Zacks
23 days ago
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
Yahoo
a month ago
IDEXX Laboratories (IDXX) Gained 27% on Improved Operating Margins
Zacks
a month ago
Top Research Reports for Lam Research, PayPal & Trane
Yahoo
a month ago
Strong Fiscal Q3 Earnings Pushed IDEXX Laboratories (IDXX) in Q4
Yahoo
a month ago
IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 19% CAGR delivered to shareholders
Yahoo
a month ago
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Yahoo
2 months ago
Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc (IDXX)
Yahoo
2 months ago
Idexx (IDXX) Down 1.5% Since Last Earnings Report: Can It Rebound?
Zacks
2 months ago
Idexx (IDXX) Down 1.5% Since Last Earnings Report: Can It Rebound?